|
Video: What is a Stock Split?
|
|
Zalicus is a biopharmaceutical company engaged in developing drug candidates with a focus on the treatment of pain. Co.'s primary product candidate is Z160, an oral N-type calcium channel blocker that Co. is seeking to develop for the treatment of chronic pain. Co.'s other product candidate is Z944, an oral T-type calcium channel blocker that Co. is seeking to develop for the treatment of pain indications. In addition, Co. is performing discovery research and preclinical development activities on its proprietary selective ion channel modulators targeting the Nav1.7 sodium channel as well as N-type and T-type calcium channels, as part of a research collaboration with Hydra Biosciences, Inc. According to our ZLCS split history records, ZLCS has had 1 split. | |
|
ZLCS (ZLCS) has 1 split in our ZLCS split history database. The split for ZLCS took place on October 03, 2013. This was a 1 for 6 reverse split, meaning for each 6 shares of ZLCS owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 166.666666666667 share position following the split.
When a company such as ZLCS conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ZLCS split history from start to finish, an original position size of 1000 shares would have turned into 166.666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into ZLCS shares, starting with a $10,000 purchase of ZLCS, presented on a split-history-adjusted basis factoring in the complete ZLCS split history.
ZLCS -- use the split history when considering split-adjusted past price performance. |
|
Date |
Ratio |
10/03/2013 | 1 for 6 |
|
|